Notice of Results

RNS Number : 8976O

Hutchison China Meditech Limited

07 July 2010

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Notice of Announcement of 2010 Interim Results

London: Wednesday, 7 July 2010: Chi-Med will be announcing its interim results for the six months ended 30 June 2010 on Thursday, 29 July 2010.

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone: [phone] Mobile: [phone] Mobile: [phone]
Lazard & Co., Limited Paul Gismondi Nick Fowler	Telephone: [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

NORDMGGNGVVGGZM